Minji Wei

460 total citations · 1 hit paper
13 papers, 345 citations indexed

About

Minji Wei is a scholar working on Pharmacology, Epidemiology and Pharmacology. According to data from OpenAlex, Minji Wei has authored 13 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Epidemiology and 3 papers in Pharmacology. Recurrent topics in Minji Wei's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pneumonia and Respiratory Infections (3 papers) and Epilepsy research and treatment (2 papers). Minji Wei is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Pneumonia and Respiratory Infections (3 papers) and Epilepsy research and treatment (2 papers). Minji Wei collaborates with scholars based in China, United Kingdom and United States. Minji Wei's co-authors include Yuan Lü, William C. Cho, Xiwei Ji, Xiangrui Meng, Huifang Tian, Caiyun Zhao, Huimin Qi, Li Zhang, Yuan Lv and Li Wang and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Biomedicine & Pharmacotherapy.

In The Last Decade

Minji Wei

12 papers receiving 344 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemoresistance mechanisms of breast cancer and their countermeasures

2019 251 citations Xiwei Ji, Yuan Lü et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minji Wei China	7	168	97	65	46	41	13	345
Juan Zou China	13	220 1.3×	87 0.9×	51 0.8×	35 0.8×	35 0.9×	30	405
Xiwei Ji China	9	229 1.4×	129 1.3×	77 1.2×	64 1.4×	48 1.2×	21	459
Wei‐Bang Yu China	11	161 1.0×	60 0.6×	44 0.7×	28 0.6×	27 0.7×	15	402
Chunjie Wen China	15	316 1.9×	105 1.1×	162 2.5×	60 1.3×	48 1.2×	29	519
Vinayak Jamdade India	8	155 0.9×	81 0.8×	81 1.2×	18 0.4×	39 1.0×	10	390
Dong Hou China	11	274 1.6×	86 0.9×	78 1.2×	54 1.2×	34 0.8×	12	489
Chengwu Shen China	11	179 1.1×	70 0.7×	63 1.0×	44 1.0×	43 1.0×	28	421
Mayrel Palestino Domínguez Mexico	9	201 1.2×	99 1.0×	81 1.2×	26 0.6×	27 0.7×	13	439
Chin-Mu Hsu Taiwan	16	163 1.0×	44 0.5×	41 0.6×	26 0.6×	20 0.5×	21	478
Ajeet Kumar Verma India	11	187 1.1×	72 0.7×	47 0.7×	38 0.8×	31 0.8×	16	349

Countries citing papers authored by Minji Wei

Since Specialization

Citations

This map shows the geographic impact of Minji Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minji Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minji Wei more than expected).

Fields of papers citing papers by Minji Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minji Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minji Wei. The network helps show where Minji Wei may publish in the future.

Co-authorship network of co-authors of Minji Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Minji Wei. A scholar is included among the top collaborators of Minji Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minji Wei. Minji Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Li, Xin, et al.. (2022). Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model. Journal of Antimicrobial Chemotherapy. 78(1). 141–149. 5 indexed citations

2.

Cui, Hong, Caiyun Zhao, Yuan Lv, et al.. (2021). Safety, Pharmacokinetics and Pharmacodynamics of Multiple Escalating Doses of PEGylated Exenatide (PB-119) in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 46(2). 265–275. 3 indexed citations

3.

Cui, Hong, Caiyun Zhao, Yuan Lv, et al.. (2020). Safety, Tolerability and Pharmacokinetics of Single Dose Polyethylene Glycolated Exenatide Injection (PB-119) in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 45(3). 361–369. 4 indexed citations

4.

Zhao, Caiyun, Yuan Lv, Hong Cui, et al.. (2020). Phase I safety, tolerability, and pharmacokinetic studies of tetramethylpyrazine nitrone in healthy Chinese volunteers. Drug Development Research. 82(1). 97–107. 6 indexed citations

5.

Chen, Nan, Hao Shi, Luxia Zhang, et al.. (2020). GFR Estimation Using a Panel of Filtration Markers in Shanghai and Beijing. Kidney Medicine. 2(2). 172–180. 9 indexed citations

6.

Ji, Xiwei, Yuan Lü, Huifang Tian, et al.. (2019). Chemoresistance mechanisms of breast cancer and their countermeasures. Biomedicine & Pharmacotherapy. 114. 108800–108800. 251 indexed citations breakdown →

7.

Zhao, Caiyun, Yuan Lv, Yan Zhu, et al.. (2019). A First-in-Human Safety, Tolerability, and Pharmacokinetics Study of Benapenem in Healthy Chinese Volunteers. Antimicrobial Agents and Chemotherapy. 63(3). 10 indexed citations

8.

Zhao, Caiyun, Yuan Lv, Xiangyan Li, et al.. (2018). Effects of Nemonoxacin on Thorough ECG QT/QTc Interval: A Randomized, Placebo- and Positive-controlled Crossover Study in Healthy Chinese Adults. Clinical Therapeutics. 40(6). 983–992. 7 indexed citations

9.

Zhao, Caiyun, Yuan Lv, Minji Wei, et al.. (2018). A Randomized Study of the Single-Dose Safety, Pharmacokinetics, and Food Effect of Chinfloxacin and Its Effect on Thorough QT/QTc Interval in Healthy Chinese Volunteers. Antimicrobial Agents and Chemotherapy. 62(12).

10.

Ji, Xiwei, Tianyan Zhou, Yuan Lü, et al.. (2015). Breast cancer treatment and sulfotransferase. Expert Opinion on Therapeutic Targets. 19(6). 821–834. 4 indexed citations

11.

Gao, Lei, et al.. (2015). A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia. Chinese Medical Journal. 128(9). 1160–1164. 2 indexed citations

12.

Wang, Yinghui, Li Wang, Wei Lu, et al.. (2012). Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy. Acta Pharmacologica Sinica. 33(6). 845–851. 12 indexed citations

13.

Zhang, Li, Minji Wei, Caiyun Zhao, & Huimin Qi. (2008). Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes. Acta Pharmacologica Sinica. 29(12). 1507–1514. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact